WG
SLS icon

Winton Group’s SELLAS Life Sciences SLS Stock Holding History

Winton Group’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-12,105
Closed -$35K – 1603
2020
Q2 		$35K Sell
12,105
-6,771
-36% -$18.4K ﹤0.01% 1424
2020
Q1 		$33K Buy
18,876
+7,832
+71% +$20.2K ﹤0.01% 1363
2019
Q4 		$47K Buy
+11,044
New +$59.5K ﹤0.01% 1507

Other funds holding SLS

WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
EH
Equitable Holdings New York $16.7B AUM 24.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
MML Investors Services
MML Investors Services Springfield, Massachusetts $49B AUM 25.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Winton Group's SLS Position: Q3 2020 in Review

Winton Group sold out of SELLAS Life Sciences (SLS) in Q3 2020, closing a stake of 12,105 shares — an estimated $35K sold.

Winton Group first reported a position in SLS in Q4 2019 and held it in 3 quarters. The position peaked at $47K in Q4 2019. 14 funds tracked by Wall St. Rank hold SLS as of Q3 2020.

  • Winton Group reported no remaining SELLAS Life Sciences position as of Q3 2020 after selling out during the quarter.
  • Winton Group sold 12,105 SELLAS Life Sciences shares in Q3 2020, an estimated $35K.
  • Winton Group first reported a position in SELLAS Life Sciences in Q4 2019 and held it in 3 quarters.
  • Winton Group's SELLAS Life Sciences position peaked at $47K in Q4 2019.
  • 14 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q3 2020.

Based on Winton Group's 13F filing for Q3 2020, filed 30 Oct 2020.